Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), Madrid. Spain.
Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg, Denmark.
Expert Rev Neurother. 2023 Feb;23(2):179-186. doi: 10.1080/14737175.2023.2185138. Epub 2023 Mar 1.
COVID19 associated headaches are highly common and there is currently an unmet need to better understand their association with SARSCoV2 variants. Headaches are a prevalent symptom in the acute phase of COVID19 and are associated with a better prognosis and better immune response. They are also a relevant post-COVID symptom.
This article analyses the differences in the prevalence of headache as an onset symptom and in post-COVID headache among the different SARS-CoV-2 variants: the historical strain, Alpha, Delta and Omicron. The different pathophysiological mechanisms by which SARS-CoV-2 infection may cause headache are also discussed.
The presence of headache at the acute phase is a risk factor for post-COVID headache, whereas a history of primary headache does not appear to be associated with post-COVID headache. The prevalence of headache as an onset symptom appears to be variable for the different SARS-CoV-2 variants, but current data are inconclusive. However, the current evidence also suggests that headache represents a prevalent symptom in the acute and post-infection COVID-19 phase, regardless of SARS-CoV-2 variant.
COVID-19 相关头痛非常常见,目前人们迫切需要更好地了解其与 SARS-CoV-2 变体的关联。头痛是 COVID-19 急性期的常见症状,与预后较好和更好的免疫反应相关。头痛也是 COVID 后的相关症状。
本文分析了不同 SARS-CoV-2 变体(原始株、Alpha、Delta 和 Omicron)作为首发症状的头痛和 COVID 后头痛的患病率差异。还讨论了 SARS-CoV-2 感染可能导致头痛的不同病理生理机制。
急性期头痛是 COVID 后头痛的危险因素,而原发性头痛病史似乎与 COVID 后头痛无关。不同 SARS-CoV-2 变体首发症状头痛的患病率似乎不同,但目前的数据尚无定论。然而,目前的证据还表明,无论 SARS-CoV-2 变体如何,头痛都是 COVID-19 急性期和感染后阶段的常见症状。